Greenwich LifeSciences (GLSI) Change in Cash (2019 - 2026)

Greenwich LifeSciences (GLSI) has 7 years of Change in Cash data on file, last reported at $2.4 million in Q4 2025.

• Quarterly Change in Cash rose 237.02% year-over-year to $2.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.1 million (up 172.0% YoY) and the FY2025 annual result came in at $2.1 million, up 172.0% from the prior year.
• Change in Cash improved to $2.4 million in Q4 2025, from $681877.0 in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $2.4 million in Q4 2025 to a low of -$7.5 million in Q1 2022.
• A 5-year average of -$1.1 million and a median of -$1.4 million in 2024 frame the typical range for Change in Cash.
• Annual changes were most pronounced in 2022 — Change in Cash plunged 527.68% — and 2024, when it jumped 277.76%.
• Tracing GLSI's Change in Cash over 5 years: stood at -$1.7 million in 2021, then declined by 27.52% to -$2.2 million in 2022, then gained by 0.73% to -$2.2 million in 2023, then climbed by 19.67% to -$1.7 million in 2024, then jumped by 237.02% to $2.4 million in 2025.
• The last three Change in Cash figures came in at $2.4 million (Q4 2025), $681877.0 (Q3 2025), and $375142.0 (Q2 2025), per Business Quant data.